Abstract

BackgroundStudies of chronic diseases are associated with a financial burden on households. We aimed to determine if survivors of acute coronary syndrome (ACS) experience household economic burden and to quantify any potential burden by examining level of economic hardship and factors associated with hardship.MethodsAustralian patients admitted to hospital with ACS during 2-week period in May 2012, enrolled in SNAPSHOT ACS audit and who were alive at 18 months after index admission were followed-up via telephone/paper survey. Regression models were used to explore factors related to out-of-pocket expenses and economic hardship.ResultsOf 1833 eligible patients at baseline, 180 died within 18 months, and 702 patients completed the survey. Mean out-of-pocket expenditure (n = 614) in Australian dollars was A$258.06 (median: A$126.50) per month. The average spending for medical services was A$120.18 (SD: A$310.35) and medications was A$66.25 (SD: A$80.78). In total, 350 (51 %) of patients reported experiencing economic hardship, 78 (12 %) were unable to pay for medical services and 81 (12 %) could not pay for medication. Younger age (18–59 vs ≥80 years (OR): 1.89), no private health insurance (OR: 2.04), pensioner concession card (OR: 1.80), residing in more disadvantaged area (group 1 vs 5 (OR): 1.77), history of CVD (OR: 1.47) and higher out-of-pocket expenses (group 4 vs 1 (OR): 4.57) were more likely to experience hardship.ConclusionSubgroups of ACS patients are experiencing considerable economic burden in Australia. These findings provide important considerations for future policy development in terms of the cost of recommended management for patients.

Highlights

  • Studies of chronic diseases are associated with a financial burden on households

  • Of 3381 Australian patients from 251 participating hospitals who participated in SNAPSHOT acute coronary syndrome (ACS), 1833 had ACS and were admitted to one of the 152 New South Wales (NSW)/ QLD hospitals and were included in this present analysis

  • Excluding 180 (10 %) patients who died in hospital and after discharge, 1653 (90 %) NSW/QLD patients were contacted for follow-up at 18 months

Read more

Summary

Introduction

We aimed to determine if survivors of acute coronary syndrome (ACS) experience household economic burden and to quantify any potential burden by examining level of economic hardship and factors associated with hardship. Acute coronary syndrome (ACS) which includes acute myocardial infarction (MI) and unstable angina (UA) has a high incidence globally [1]. As the Recommended treatment for patients with ACS includes coronary revascularization, adherence to long-term therapies such as: antiplatelet agent(s), beta-blocker, angiotensin-converting enzyme inhibitor, statin and other therapies as appropriate, cardiac rehabilitation services and follow-up appointments with treating physicians [1]. Australian patients benefit from the national health insurance system, Medicare.

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.